Name ЦЕНА, У.Е.* Price, ₽ Code
Laboratory services
CLINICAL DIAGNOSTIC LABORATORY > BLOOD ANALYSIS
Cell Blood Count+differential 65 6 421 A000
General blood test, extended (CBC + differential + ESR + reticulocyte count) 101 9 977 A000_EXT
Cell Blood Count 37 3 655 A002
Sedimentation rate 23 2 272 A005
Reticulocytes 18 1 778 A008
Matching of blood and compatibility test 604 59 662 A009
Malaria test 89 8 791 M125
URINE ANALYSIS
Standard urine test 18 1 778 B500
Standard urine test with microscopy 32 3 161 B502
Urine pregnancy test (screening) 18 1 778 B510
Nechiporenko urine test 26 2 568 B511
Zimnitsky urine test 70 6 914 B512
3-portions urine test examination 53 5 235 B513
2-portions urine test examination 35 3 457 B514
Creatinine Clearance 70 6 914 B517
STOOL ANALYSIS
Fecal examination for pancreatic elastase-1 69 6 816 B306
Coprology total 35 3 457 M105
Coprology (occult blood) 18 1 778 M110
Carbohydrates in faeces 53 5 235 M111
Enterobiasis 26 2 568 M115
Eggs of helminths (+protozoa) 35 3 457 M120
Protozoa in faeces 26 2 568 M122
Adenovirus and rotavirus (in stool) 36 3 556 M390
Cryptosporidium, Giardia, Entamoeba histolytica in stool 54 5 334 M392
Helicobacter pylori(in stool) 35 3 457 M391
Determination of Escherichia coli O157: H7 (stool) 67 6 618 M393
Norovirus in stool 33 3 260 M394
Calprotectin in stool (quantitative) 67 6 618 M395
Clostridium Difficile Toxin A & B 86 8 495 M396
SPUTUM ANALYSIS
Standard sputum test 35 3 457 M150
Nasal slime general clinical research 35 3 457 M002
M. Tuberculosis in sputum 44 4 346 M355
SKIN& NAIL PLATES
Microscopic examination of a scraping from the skin, papules and ulcers on the edges parasitos 30 2 963 M126
Examination of skin plate or nail plate for pathogenic fungi (one test) 62 6 124 M155
Demodex folliculorum 26 2 568 M210
BIOCHEMICAL HAIR ANALYSIS
Heavy metals and trace elements (23 elements) complex hair test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 200 19 756 B208
TESTS OF THE UROGENITAL SYSTEMS
Standard Vaginal Smear Test 32 3 161 M220
Standard Cervical Smear Test 26 2 568 M221
Standard Urethral Smear Test 26 2 568 M222
Standard prostatic fluid test 35 3 457 M223
SEROUS CAVITIES& CYSTS FLUID TESTS
Standard Synovial Fluid Test 35 3 457 B620
Standard Serous Fluid test 35 3 457 B621
CEREBROSPINAL FLUID TESTS
Standard cerebrospinal fluid test 44 4 346 B622
Glucose in cerebrospinal fluid 23 2 272 B623
Protein in cerebrospinal fluid 23 2 272 B624
HEMOSTASIS SYSTEM
APTT 26 2 568 A020
Prothrombin+INR 37 3 655 A025
Thrombin time 29 2 865 A027
Fibrinogen 23 2 272 A030
Antithrombin III 35 3 457 A035
Protein-C 62 6 124 C139
Protein-S 62 6 124 C142
D-DIMER 83 8 199 C515
Lupus anticoagulant (panel) 70 6 914 C305
Platelet aggregation 110 10 866 A033
FACTOR VON 227 22 423 A031
Fractions of hemoglobin (carboxyhemoglobin and methemoglobin) 41 4 050 A068
BLOOD DRUG RATES
Folic acid 37 3 655 B142
Determination of ethanol in the blood 79 7 803 C710
Digoxin 100 9 878 T010
Determination of phenobarbital in blood 70 6 914 T015
Phenytoin 70 6 914 T020
Valproic Acid 70 6 914 T025
Carbamazepine 70 6 914 T030
Determination of tacrolimus in blood 91 8 989 T080
Levetiracetam (Keppra) 133 13 137 T085
Therapeutic drug monitoring of Topiramate 62 6 124 T097
Therapeutic drug monitoring of oxcarbazepine by its active metabolite (single sample analysis) 62 6 124 T098
Determination of the concentration of Amikacin in the blood 62 6 124 T100
The determination of the concentration of Gentamicin in the blood 62 6 124 T101
Determine the concentration of Vancomycin in the blood 62 6 124 T102
Therapeutic drug monitoring of methotrexate in the blood 62 6 124 T103
Determination of the concentration of Paracetamol (Acetaminophen) in the blood 62 6 124 T106
Determination of Vitamin B2 blood concentration (HPLC) 35 3 457 B705
Determination of Vitamins of group D blood concentration (25-OH-D2 and 25-OH-D3) - a detailed study (HPLC) 66 6 519 B706
Comprehensive assessment of oxidative stress (Vitamin C, malondialdehyde, vitamin E, coenzyme Q10, glutathione, 8-OH-deoxyguanosine, beta-carotene) 222 21 929 B707
Determination of the concentration of coenzyme Q10 in the blood (HPLC) 35 3 457 B708
Level of adrenaline, norepinephrine, dopamine, serotonin HVA, VMK,5-OIUA in urine determination (HPLC, GC-MS) 44 4 346 C465
Determination of the concentration of melatonin in daily urine (HPLC) 41 4 050 C466
Determination of the concentration of Timipramine in the blood (HPLC) 53 5 235 T120
Determination of Voriconazole Plasma Concentration by HPLC Technique 62 6 124 T107
NARCOTIC SCREENING
Drug screening in urine 70 6 914 T075
Hair analysis for determination of drug means, psychotropic or potent substances. (method GC – MS, HPLC) 237 23 410 T087
Amphetamines in urine (quantitative) 35 3 457 T088
Cocaine in urine (quantitative) 35 3 457 T089
Cannabinoids in urine (quantitative) 35 3 457 T090
Barbiturates in urine (quantitative) 35 3 457 T091
Benzodiazepines in urine (quantitative) 35 3 457 T092
Opiates in urine (quantitative) 35 3 457 T095
Urinalysis "bad habits" (nicotine, a psychotropic and narcotic substance, a psychoactive drug substances) 73 7 211 T096
Determination of nicotine and its metabolites in urine for differential diagnosis of active and passive smoking: nicotine, cotinine (GH-MS method) 48 4 741 T099
Complex "Endocrine disruptors" 290 28 646 T139
BLOOD BIOCHEMISTRY
Determination of the level of vitamin B12 (cyanocobalamin) in the blood 44 4 346 A060
Iron saturation of transferrin + Transferrin + Iron 55 5 433 B002
Ceruloplasmin 67 6 618 B003
Eosinophil Cationic Protein (ECP) 67 6 618 B004
Cuprum 28 2 766 B007
Glucose 21 2 074 B100
Standard glucose tolerance test 44 4 346 B101
Vitamin D 150 14 817 B102
Vitamin A 116 11 458 B103
Vitamin B1 116 11 458 B104
Cholesterol 23 2 272 B105
Pregnancy glucose tolerance test 44 4 346 B107
Vitamin B5 116 11 458 B108
Vitamin B6 116 11 458 B109
Cholesterol-HDL 27 2 667 B110
Vitamin C 116 11 458 B112
Vitamin E 116 11 458 B113
Vitamin K 110 10 866 B114
Cholesterol-LDL 27 2 667 B115
Lactate 35 3 457 B118
Triglycerides 19 1 877 B120
Angiotensin converting enzyme (ACE) 61 6 025 B122
Bilirubin total 20 1 976 B125
Bilirubin direct 19 1 877 B130
Albumin 22 2 173 B135
Homocysteine 94 9 285 B137
Creatinine 23 2 272 B140
Zink 54 5 334 B144
Iron 23 2 272 B145
Litium 99 9 779 B148
Iron binding capacity 26 2 568 B150
Total protein 20 1 976 B155
Protein fractionation (Electrophoresis) 35 3 457 B160
Lipoprotein A 35 3 457 B165
APO-A-1 protein 35 3 457 B166
APO-B protein 35 3 457 B167
Urea 21 2 074 B170
Uric acid 34 3 358 B175
Fructosamine 26 2 568 B180
Determination of bile acids in blood 57 5 630 B188
Calcium (total) 23 2 272 B200
Calcium (ionised) 27 2 667 B202
Heavy metals and trace elements (23 elements Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb) complex blood test 211 20 842 B203
Sodium/Potassium/Chloride 41 4 050 B205
Blood gases: рО2,рСО2,рН from venous blood + calculating parameters 56 5 532 B207
Blood gases: рО2,рСО2,рН from arterial blood + calculating parameters 35 3 457 B209
Magnesium 19 1 877 B210
Phosphate inorganic 18 1 778 B215
Complex blood analysis: gas and electrolyte compositions, glucose, lactate with calculated parameters in venous blood (for Maternity hospital) 59 5 828 B218
Complex blood analysis gas and electrolyte compositions, glucose, lactate in capillary blood (for Maternity hospital) 59 5 828 B221
Amylase 22 2 173 B300
Amylase pancreatic 23 2 272 B305
Lipase 23 2 272 B310
Lactatedehydrogenase (LDH) 19 1 877 B315
Erythropoietin 62 6 124 B317
Creatine Kinase 19 1 877 B320
Creatine Kinase MB 22 2 173 B325
Gamma Glutamyle Transferase (GGT) 27 2 667 B330
Acid phosphatase 22 2 173 B335
Alk. Phosphatase 30 2 963 B340
Alanine Amino Transferase (ALT) 23 2 272 B345
Aspartate Amino Transferase (AST) 23 2 272 B350
Cholinesterase 24 2 371 B360
Determination of C1 esterase inhibitor in blood 59 5 828 B362
C-Reactive Protein 27 2 667 B400
C-reactive protein high sensitivity 41 4 050 B401
Rheumatoid Factor 26 2 568 B405
Anti-streptolysin O titre 26 2 568 B410
Alfa-1-antitrypsin 35 3 457 B411
Ferritin 41 4 050 C415
Haemoglobin A1C 42 4 149 B430
Myoglobin 62 6 124 B435
Transferrin 35 3 457 B440
Troponin I 65 6 421 B445
Troponin T 62 6 124 B450
BNP (brain natriuretic peptide) 148 14 619 B451
Determination of a functional C1 esterase inhibitor 59 5 828 B452
The N-terminal peptide NT-proBNP 111 10 964 B556
Alpha-2-Macroglobuline 62 6 124 B604
Haptoglobin 62 6 124 B610
Tandem mass spectrometry (spectrum acylcarnitines, amino acids, organic acids 183 18 076 B700
Procalcitonin (quant) 118 11 656 B702
Determination of renin activity, direct determination in the blood 13 1 284 B723
Study of the level of aldosterone in the blood 21 2 074 B724
URINE BIOCHEMISTRY > Urine Biochemistry- Random Portion
Urolithiasis Early Diagnostics 62 6 124 B021
Determination of total protein in the urine (single serving) 18 1 778 B025
Urea (random portion) 17 1 679 B132
Uric acid (random portion) 17 1 679 B133
The content of Cu (copper) in the urine (a single portion of urine) 18 1 778 B139
Determination of iodine content in urine - I (iodine) 15 1 482 B149
Glucose (random portion) 18 1 778 B173
Alpha Amylase (random portion) 24 2 371 B182
NA+/K+/Cl (random portion) 26 2 568 B505
Heavy metals and trace elements (23 elements) complex urine test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 200 19 756 B204
Calcium (random portion) 24 2 371 B134
The content of Cu (copper) in the urine (daily) 18 1 778 B008
Gas chromatography of urine (organic aciduria) 332 32 794 B703
Biochemical Urine Analysis - 24h
Determination of microalbumin in urine (daily urine) 24 2 371 B136
Creatinine (24h) 24 2 371 B141
Urea (24h) 24 2 371 B171
Uric acid (24h) 24 2 371 B176
Phosphate inorganic (24h) 24 2 371 B177
Magnesium (24) 24 2 371 B178
Glucose (24h) 24 2 371 B179
Determination of total protein in the urine (daily urine) 24 2 371 B183
Na (24h) 26 2 568 B506
K (24h) 26 2 568 B507
Cl (24h) 26 2 568 B508
Calcium urine test (24h) 29 2 865 B516
Oxalate in urine 53 5 235 B550
Determination of Beta-2-microglobulin (single dose of urine) 32 3 161 B558
Stone chemistry - Profile 122 12 051 B520
IMMUNOLOGY > Diagnostic Of The Body Immunological Status
Immunoglobulin A (IgA) 25 2 469 B415
Immunoglobulin M (IgM) 25 2 469 B420
Immunoglobulin G (IgG) 25 2 469 B425
Circulating Immune Complex 29 2 865 C299
IgE total 37 3 655 C300
Interferon sensibility state 389 38 424 C285
Lymphocyte subpopulations/min.panel/(CD3,CD4,CD8,CD19,CD16(56)),CD3+HL 266 26 275 C288
Lymphocyte subpopulations (ext. panel) CD3,CD4,CD8,CD16(56),CD19,CD3+ HLA-DR+,CD3+CD16(56)+(EK-T),CD8+CD38+CD25+,CD3+CD56+,CD95,CD4/CD8 253 24 991 C289
Compliment Componenta C3 44 4 346 C293
Compliment Componenta C4 44 4 346 C294
Neutrophilic Bactericidal Activity (HCT test) 35 3 457 C295
Interleukin 6 61 6 025 C290
Interleukin 8 45 4 445 C291
Interleukin 10 45 4 445 C296
Tumor Necrosis Factor 50 4 939 C298
Interleukin 1 Beta 67 6 618 C281
Determination of amyloid - beta (1-42) in blood and in cerebrospinal fluid 130 12 841 C307
Oligoclonal IgG in liquorrhea & serum 160 15 804 B704
Diagnosis Of Auto-Immune Diseases
Cardiolipin antibodies, IgM 67 6 618 C023
Anti-smooth muscle antibodies (ASMA) 67 6 618 C101
Anti-mitochondrial antibodies (AMA) 67 6 618 C102
Determination of antibodies to myeloperoxidase (MPO), IgG; quantitative determination 23 2 272 C175
Determination of antibodies to proteinase 3 (PR3), IgG; highly sensitive method; quantitative determination 23 2 272 C176
Determination of antibodies against neuronal receptors and synaptic (NMDAR, LGl1, CASPR2, AMPA1R, AMPA2R, GABAb1R) in cerebrospinal fluid 352 34 770 C183
Saccharomyces cerevisiae antibodies (ASCA) 59 5 828 C201
Scl-70 antibodies 67 6 618 C203
Thyroglobulin antibody 44 4 346 C225
Thyroperoxidase antibody 46 4 544 C230
Auto AB TSH-receptor 70 6 914 C231
Antispermatic Antibodies 89 8 791 C233
AB Insulin IgG 53 5 235 C235
AB insular beta-cells 89 8 791 C236
Antibodies acetylcholine receptor 212 20 941 C240
Antibodies aquaporin 4( NMO) 107 10 569 C241
Antibodies skeletal muscles 94 9 285 C242
Antibodies gangliosides, blot 120 11 853 C243
Myositis antibodies, blot 138 13 631 C244
Anti-neuronal antibodies, blot 146 14 422 C245
Antibodies NMDA receptor 200 19 756 C246
Antibodies Sm 67 6 618 C247
Antibodies gliadine deamidated peptides IgG 59 5 828 C248
Antibodies gliadine deamidated peptides IgA 59 5 828 C249
Antibodies RNP-70 59 5 828 C250
Immunophenotypic diagnostics of Acute leukemia and evaluation of the minimal residual disease (IPT AL and MOB) 480 47 413 C252
Blood test on APG 172 16 990 C253
Evaluation of cellular immunity / Immunity / imony the status of standard (расшифровка в таблице) 86 8 495 C254
Definition of CD20 in peripheral blood 73 7 211 C256
Typing of CD-34 + cells 92 9 088 C257
Myelogram 204 20 151 C258
Study of blood serum for the presence of antibodies to muscle specific tyrosine kinase receptors by enzyme immunoassay 187 18 471 C259
Antibodies to myelin oligodendrocyte glycoprotein Anti-MOG 157 15 508 C260
Determination of Tau protein in biological fluids 191 18 867 C261
Determination of glial fibrillar acid protein (GFAP) 166 16 397 C262
Comprehensive study (immunophenotyping) panel for serous discharge: CD45/CD15/CD71/CD40/CD95/CD30/CD3/CD19 480 47 413 C263
Nuclear antibody (IF) 62 6 124 C500
Cardiolipin antibody IgG 62 6 124 C505
Cardiolipin antibody IgA 33 3 260 C506
Immunophenotypic diagnostics of lymphoproliferative diseases(IPT LLP)) 480 47 413 C521
Anti-dsDNA 70 6 914 C533
Anti-ssDNA 70 6 914 C534
Phospholipid Antibody IgG 70 6 914 C535
Phospholipid Antibody IgM 70 6 914 C536
Antibodies Prothrombin 53 5 235 C830
Antibodies Gliadin IgA 53 5 235 C840
Anti-Transglutaminase IgG 62 6 124 C841
Anti-Transglutaminase IgA 62 6 124 C842
Antibodies Reticulin 62 6 124 C845
Antibodies Endomysium 62 6 124 C846
Antibodies Platelet 70 6 914 C847
Antibodies Basic Skin Membrane 98 9 680 C848
Determination of antibodies to the basement membrane of the glomeruli of the kidneys, IgG 45 4 445 C849
Antibodies Gliadin IgG 53 5 235 C850
Beta2 – glycoprotein antibodies 67 6 618 C851
Annexin V antibodies 67 6 618 C852
ENA – extractive nuclear antibodies screen 81 8 001 C853
ANCA –Anti-Neutrophil cytoplasmatic antibodies 67 6 618 C854
Anti CCP – Anti-cyclic citrullinated peptide antibodies 67 6 618 C855
Immune Hematological Analysis
Determination of free light chains FLC in blood 83 8 199 A069
Determination of free light chains (FLC) in urine 69 6 816 A070
ONCOLOGICAL TESTS
PSA total 41 4 050 C405
PSA free 41 4 050 C410
AFP 39 3 852 C420
CEA 41 4 050 C425
CA 125 51 5 038 C430
CA 19-9 41 4 050 C435
CA 15-3 39 3 852 C440
CA 72 - 4 53 5 235 C442
Neuron-Specific Enolase (NSE) 79 7 803 C443
B2 microglobulin 44 4 346 C445
Cyfra-21-1 53 5 235 C820
Squamous Cell Carcinoma (SCC) 52 5 136 C822
UBC (Bladder Cancer Antigen) in urine 52 5 136 C821
HE4 53 5 235 C823
Chromogranin A 70 6 914 C824
Study of the level of the tumor-associated marker CA 242 in the blood 34 3 358 C537
SEROLOGY > Syphilis Diagnosis
Determination of anti-cardiolipin antibodies by microreaction precipitation (RPR) (Diagnosis of syphilis) 35 3 457 S000
Determination of antibodies to Treponema pallidum (total) 45 4 445 S001
Determination of antibodies to Treponema pallidum by indirect hemagglutination(TPHA) 44 4 346 S010
Detection of antibodies to Treponema pallidum by the RIBT method 64 6 322 S011
Detection of antibodies to Treponema pallidum by the RIF method 37 3 655 S012
Determination of anti-Treponema pallidum IgG immunoblot 136 13 434 S091
Determination of anti-Treponema pallidum IgM immunoblot 136 13 434 S092
Determination of antibodies to Treponema pallidum by the RIF method in liquor 37 3 655 S105
Isoserological Study
ABo Blood group+rhesus factor 46 4 544 A050
Antierythrocytic antibodies (screening) 56 5 532 A055
Direct Cumbs test 44 4 346 A056
Phenotyping Rh and Kell 60 5 927 A064
DIAGNOSIS OF VIRAL INFECTIONS
Anti-HIV 1, 2 + antigen p24 65 6 421 C001
Anti-HIV 1, 2 + antigen p24 state certificate 105 10 372 C001-SC
Anti-HAV IgM 62 6 124 C006
Hepatitis D Virus HDV antibodies, total 36 3 556 C007
HBsAg 40 3 951 C008
HBeAg 62 6 124 C010
HDV antibodies, IgM 36 3 556 C011
Anti-HBc total 53 5 235 C012
HEV antibodies, IgG 36 3 556 C013
Anti-HBc IgM 62 6 124 C014
HEV antibodies, IgM 36 3 556 C015
Anti-Hbe 62 6 124 C016
Anti-HBs quant. 62 6 124 C018
Determination of total IgG+IgM antibodies to hepatitis C virus (anti-HCV) 56 5 532 C020
Anti-HCV IgM 58 5 729 C021
Anti-CMV IgG 39 3 852 C026
Anti-CMV IgM 44 4 346 C028
Anti-Rubella IgG 39 3 852 C030
Anti-Parvovirus B19 IgG 53 5 235 C031
Anti Rubella IgM 44 4 346 C032
Anti-Parvovirus B19 IgM 53 5 235 C033
Anti Mumps IgG 70 6 914 C034
Anti Mumps IgM 70 6 914 C036
Anti Measles IgG 70 6 914 C038
Anti Measles IgM 70 6 914 C040
Human Herpes Virus 6 type antibodies (anti-HHV6) , IgG 62 6 124 C041
Anti-HSV 1 IgG 62 6 124 C044
Anti-HSV 1 IgM 70 6 914 C046
Anti-HSV 2 IgG 62 6 124 C048
Anti-HSV 2 IgM 70 6 914 C050
Anti-Varicella Zoster IgG 70 6 914 C052
Anti Varicella Zoster IgM 70 6 914 C054
Anti-EBV-VCA IgG 70 6 914 C058
Anti-EBV-VCA IgM 70 6 914 C060
IgG Respiratory syncytial virus 47 4 643 C094
IgM Respiratory syncytial virus 47 4 643 C096
IgG Dengue virus 33 3 260 C152
IgM Dengue virus 33 3 260 C153
Antibodies to Clostridium tetani (quantitative) 47 4 643 C154
Antibodies to nuclear antigen of Epstein-Barr lgG / EBV EBNA lgG 69 6 816 C155
Antibodies to early proteins of Epstein-Barr lgG / EBV EA IgG 69 6 816 C156
Adenovirus infection 89 8 791 C450
Anti- encephalitis IgG 74 7 310 C856
Anti- encephalitis IgM 74 7 310 C857
Cytomegalovirus (CMV) IgG Avidity 70 6 914 S200
Rubella IgG Avidity 51 5 038 S210
Determination of the content of antibodies to IgA SARS-CoV-2 (ELISA), COVID-19 30 2 963 C903
Determination of the level of antibodies to immunoglobulin M (IgM) S-protein SARS-CoV-2 (IHL method), qualitatively 51 5 038 C906
Determination of the level of antibodies to immunoglobulin G (IgG) S-protein SARS-CoV-2 (IHL method), quantitatively 64 6 322 C907
Detection of class G immunoglobulins to the nucleocapsid protein of the SARS-CoV-2 coronavirus, qualitatively, CLIA 51 5 038 C909
DIAGNOSTICS OF BACTERIAL INFECTIONS
Helicobacter pylori antibody quantitative 62 6 124 C062
Anti IgG Chlamydia trachomatis (IF/quant) 62 6 124 C072
Determination of antibodies to Bordetella pertussis IgA (quant.) 89 8 791 C081
Determination of antibodies to Bordetella pertussis IgG (quant.) 89 8 791 C082
Determination of antibodies to Bordetella pertussis IgM (quant.) 89 8 791 C083
M.Tuberculosis by the method of T-SPOT.TB. 174 17 187 C099
Borrelia burgdorf. IgG (qual) 89 8 791 C090
Borrelia burgdorf. IgM (qual) 89 8 791 C091
Serological diagnosis of borreliosis (immunochip) in blood and neurolynph 39 3 852 C164
Serological diagnosis of borreliosis (immunochip) in blood 21 2 074 C165
Determination of urease activity Helicobacter pylori, 13C (urease respiratory test) 51 5 038 C177
Brucella IgG 89 8 791 C645
Brucella IgM 89 8 791 C647
Chlamydia pneumoniae IgA 70 6 914 D070
Chlamydia pneumoniae IgG 70 6 914 D071
Anti IgM Chlamydia pneumoniae 70 6 914 D072
Determination of IgM class antibodies to Mycoplasma hominis (quant.) 17 1 679 D078
Determination of IgG class antibodies to Mycoplasma hominis (quant.) 13 1 284 D079
Mycoplasma pneumoniae IgA (quant) 53 5 235 D110
Mycoplasma pneumoniae IgG (qual) 53 5 235 D115
Mycoplasma pneumoniae IgM (qual) 53 5 235 D120
Determination of IgG Yersinia enterocolitica antibodies 41 4 050 D124
Determination of IgA Yersinia enterocolitica antibodies 41 4 050 D125
AB Shigella flexneri (total) 79 7 803 D322
AB Shigella sonnei (total) 79 7 803 D323
Ureaplasma urealiticum IgA 89 8 791 S070
Ureaplasma urealiticum IgG 89 8 791 S075
Anti-Salmonella A,B,C1, C2, D, E 29 2 865 S231
Anti-Salmonella Typhi Vi-antigen 29 2 865 S232
Anti-Corinebacterium Diphtheriae 29 2 865 S233
Helicobacter pylori IgM 58 5 729 C053
Helicobacter pylori IgA 58 5 729 C063
Determination of IgA class antibodies to Chlamydia trachomatis (quant.) 13 1 284 C123
Determination of lgM class antibodies to Chlamydia trachomatis (quant.) 13 1 284 C124
Determination of antigen Legionella pneumophila in urine (express test) 33 3 260 S007
Determination of streptococcus pneumoniae antigen 33 3 260 S008
HELMINTHIASIS DIAGNOSIS
Lamblia intestinalis IgG, IgM, IgA 62 6 124 D311
Lamblia intestinalis IgM 62 6 124 D312
Antibodies to Echinococcus gr. IgG (quantitatives) 85 8 396 D324
Antibodies to Opistorchis IgG (quantitatives) 85 8 396 D325
Antibodies to Toxocara IgG (quantitative) 85 8 396 D326
Antibodies to Trichinella lgG (quantitative) 85 8 396 D327
Antibodies Ascaris IgG (quantitative) 85 8 396 D328
The blood test for trichinosis (rostirolla) 30 2 963 D329
The blood test for anisakis (IgG) by ELISA 37 3 655 D332
Determination of antibodies class G (IgG) to the causative agent of leishmaniasis (IgG) in the blood by ELISA 52 5 136 D333
Strongyloides stercoralis antibodies 58 5 729 C049
Taenia solium antibodies, IgG 58 5 729 C051
Fasciola hepatica antibodies, IgG 58 5 729 C055
Schistosoma mansoni antibodies, IgG 58 5 729 C057
DIAGNOSIS OF ANIMACULAR INFECTIONS
Toxoplasma gondii IgG (quant) 39 3 852 C022
Toxoplasma gondii IgM (qual) 51 5 038 C024
Entamoeba histolytica antibodies, IgG (RPGA) 58 5 729 C075
Toxoplasma IgG Avidity 61 6 025 S220
HORMONE TESTS > Thyroid gland tests
Thyroid stimulating hormone 42 4 149 C200
Total T3 35 3 457 C205
Free T3 37 3 655 C210
Total T4 35 3 457 C215
Free T4 42 4 149 C220
Calcitonin 53 5 235 C222
Thyroglobulin 53 5 235 C223
Thyroid Binding Globulin (TBG) 53 5 235 C224
Definition of reversible T3 111 10 964 C457
Reproduction
Dihydrotestosterone 70 6 914 B151
Follicle stimulating hormone 41 4 050 C100
Luteinising hormone 41 4 050 C105
Globulin, linking sex hormones (SHBG) 65 6 421 C106
Testosterone 41 4 050 C110
Prolactin 41 4 050 C115
Testosterone Free 62 6 124 C117
Estradiol 41 4 050 C125
Estriol Free 51 5 038 C126
Progesterone 39 3 852 C130
Inhibin В 124 12 248 C141
AMH (Anti-Mullerian Hormone) 124 12 248 C143
Definition of Macroprolactin 13 1 284 C159
Androstenedione 79 7 803 C227
Beta HCG 46 4 544 C400
Androstanediol glucuronide 67 6 618 C404
Diagnostic risk of preeclampsia:PLGF; Soluble fms-like tyrosine kinase-1(sFlt-1); (sFlt-1)/ (PLGF) 112 11 063 C407
Determination of the total Testosterone level in the blood (HPLC-MS method) 26 2 568 Y010
FUNCTIONAL STATE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
Ketosteroids-17 (urine) 51 5 038 B525
17-alpha-Hydroxy-Progesteron 39 3 852 B531
Free cortisol (urine, 24h) 53 5 235 B536
Cortisol 39 3 852 C120
Dehydroepiandrosterone 44 4 346 C135
Adrenocorticotrophin 70 6 914 C140
Comprehensive blood test for unsaturated fatty acids of the Omega-3 family: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha-linolenic acid (ALA), gas chromatography - mass spectrometry (GC-MS) method 64 6 322 C178
Determination of the Omega-3 index (assessment of the risk of sudden cardiac death, myocardial infarction and other cardiovascular diseases), gas chromatography - mass spectrometry (GC-MS) method) 71 7 013 C179
A comprehensive blood test for unsaturated fatty acids of the Omega-6 family: linoleic, gamma-linolenic, digamogamma-linolenic, arachidonic, eicosadienic, docosadienic, docosatetraenoic acids, gas chromatography - mass spectrometry (GC-MS) method 64 6 322 C180
Comprehensive blood test for unsaturated fatty acids of the Omega-3 and Omega-6 family, gas chromatography - mass spectrometry (GC-MS) method 127 12 545 C181
Determination of cortisol in saliva 41 4 050 C452
Complex testing (stress, hormones): determination of cortisol and dehydroepiandrosterone in saliva 110 10 866 C453
The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, progestogen them precursors and metabolites (12 indicators) 149 14 718 C454
Saliva analysis. Steroid profile (17-OH-progesterone, androstenedione, DHEA, cortisone, cortisol, progesterone, testosterone, estradiol) HPLC method 111 10 964 C455
The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, estrogens, progestogen, their precursors and metabolites (16 indicators): 17-Oh-pregnenolone, testosterone, dehydroepiandrosterone, dehydroepiandrosterone-sulfate, аndrostenedione, cortisol, cortisone, 11-deoxycortisol, 21-deoxycortisol, deoxycorticosterone, corticosterone, estradiol, estron, estriol, progesterone, 17-hydroxyprogesterone in the blood 157 15 508 C462
DIAGNOSTICS OF CONGENITAL & HEREDITARY DISEASES
Triple test (trisomia-21; with conclusion) 1 trimester 168 16 595 G005
Triple test (trisomia-21; with conclusion) 2 trimester 168 16 595 G007
Mucoviscidosis CFTR 398 39 313 G123
A study of the fragmentation of sperm DNA by the method of SCD 440 43 462 G423
Study of sperm fertility using method TUNEL 417 41 190 G500
Karyotype determination (+ photo) without aberrations 166 16 397 G512
Comparison of information for frequent mutations in the DMPK gene and Myotonic dystrophy 141 13 928 G516
Comparison of information for frequent mutations in the ZNF9 gene in Myotonic dystrophy 141 13 928 G517
METABOLISM OF BONE TISSUE
Osteocalcin 61 6 025 C131
Parathormone 65 6 421 C132
Beta – CrossLaps (product of degradation of I type collagen) 58 5 729 C144
Bone resorption - deoxypiridinolin 89 8 791 C147
Study of the level of N-terminal propeptide of type 1 procollagen (P1NP) in the blood 23 2 272 C182
METABOLIC NATRIUM & WATER CONTROL OF HORMONE SYSTEMS > SOMATOTROPH FUNCTIONS OF THE PITUITARY GLAND
Human growth hormone 61 6 025 B526
Somatomedin-C 61 6 025 B527
INCRETORY FUNCTION OF PANCREATIC
Insulin 56 5 532 B532
Proinsulin 79 7 803 B533
С-peptide 62 6 124 B534
Antibody-GAD 70 6 914 B539
Leptin 70 6 914 C108
Gastro panel (pepsinogen I, pepsines Helicobacter pyloriogen II, gastrin 17 (basal), IgG antibodi) 100 9 878 C146
Melatonin 65 6 421 C158
INCRETORY FUNCTION OF THE GASTROINTESTINAL TRACT
Gastrin 70 6 914 B535
BIOGENIC AMINES
Serotonin 79 7 803 C700
Histamine 79 7 803 C800
FUNCTIONAL STATW OF SYMPATHIC-ADRENAL SYSTEM
Catecholamines and serotonin 48 4 741 C157
Determination of catecholamines in daily urine (noradrenaline, adrenaline, dopamine) 79 7 803 C118
Examination of daily urine levels: homovanilinic acid (GVK), vanillin-mandelic acid (IUD), 5-hydroxyindoleacetic acid (5-OIAA) 34 3 358 C172
Definition of free fractions of a metanefrin and normetanefrin (nekonyyugirovanny with SO4) in urine, 24 h. 37 3 655 C173
Determination of total epinephrine and norepinephrine metabolites: metanephrine, normetanephrine (free and conjugated with SO4) in urine, 24 h. 37 3 655 C174
ALLERGOLOGY > Specific Ige
Antibacterial drugs (antibiotics) (specific IgE), one name. 17 1 679 C362
Analgesics and non-steroidal anti-inflammatory drugs (specific IgE). One name. 17 1 679 C363
Local anesthetics (specific IgE). One name. 17 1 679 C364
Antibacterial drugs (antibiotics) (specific IgG). One name. 32 3 161 C365
Analgesics and non-steroidal anti-inflammatory drugs (specific IgG). One name. 31 3 062 C366
Local anesthetics (specific IgG). One name. 31 3 062 C367
Determination of the allergenic complex Allergochip ALEX2 (Allergy Explorer), 300 allergocomponents and total IgE 741 73 194 C401
SPECIFIC IgG
Determination of IgG class antibodies to 90 food allergens (food intolerance) 425 41 980 C341
Determination of class-specific immunoglobulin (IgG) for evaluation of nutritional maladjustment within the program "Immunohealth IT" 506 49 981 C463
PCR
DNA Salmonella, Shigella, Campylobacter, Adenovirus, DNA E.coli(EIEC), RNA Rotavirus, Astrovirus, Norovirus G2 in stool 47 4 643 P018
DNA Salmonella species in stool 33 3 260 P019
Colibacillosis 53 5 235 P021
DIAGNOSIS OF VIRAL INFECTIONS (PCR)
Mycoplasma pneumoniae DNA 29 2 865 P009
RNA of influenza virus А, А/Н1N1/CA/2009, B 89 8 791 P029
HSV I & II 45 4 445 P030
Herpes Simplex virus II 26 2 568 P033
Varicella-Zoster virus 26 2 568 P042
Cytomegalovirus 46 4 544 P070
Epstein-Barr virus 26 2 568 P080
Rubella Virus in blood (qual) 53 5 235 P004
Herpes Simplex virus VI (qual) 24 2 371 P120
Enterovirus (RNA) 44 4 346 P125
DNA Pneumocystis carinni 23 2 272 P126
ARVI diagnostic: RNA of respiratory syncytial virus, RNA of metapneumovirus, RNA of parainfluenza virus 1,2,3,4 types, RNA of rhinoviruses, DNA of adenoviruses B,C,E groups, DNA of bocaviruses 67 6 618 P127
Laboratory examination of tick to identify RNA/DNA pathogens transmitted by ticks: tick-borne encephalitis, borreliosis (Lyme disease), anaplasmosis, ehrlichiosis 92 9 088 P128
RNA Zika virus (blood) 101 9 977 P129
RNA Zika virus (ejaculate) 44 4 346 P130
RNA Zika virus (Amniotic fluid) 44 4 346 P131
Agroforestry-34 A screening study of the microflora of the urogenital tract of men (quantitative) 89 8 791 P133
Familar-24 Screening study of the microflora of the urogenital tract in women (quantitative) 59 5 828 P134
Neisseria meningitidis; Haemophilus influenzae; Streptococcus pneumonia: detection of DNA 19 1 877 P135
Determination of HCV RNA/ HBV DNA/ RNA HIV type 1 and 2 (ultra-sensitive study) 89 8 791 P136
Material sampling for diagnostics of T-cell immunological status in relation to certain antigens of the SARS-CoV-2 coronavirus 252 24 892 P143
Molecular-biological qualitative study of biomaterial on SARS-CoV-2 (COVID-19), isothermal amplification 165 16 298 P144
Identification of Omicron and Delta coronavirus SARS-CoV-2 RNA variants 165 16 298 P145
DIAGNOSIS OF BACTERIAL INFECTIONS (PCR)
Chlamydia pneumoniae 26 2 568 P001
M.Tuberculosis-M.bovis 29 2 865 P036
Streptococcus group A (pyogenes) 29 2 865 P038
Listeria monocytogenes 29 2 865 P065
Pseudomonas aeruginosa 29 2 865 P075
Bordetella pertussis (PCR) 29 2 865 P085
Helicobacter pylori 51 5 038 P095
Haemophilus influenzae 26 2 568 P097
Streptococcus pneumoniae 26 2 568 P098
DNA Treponema pallidum 26 2 568 P099
Legionella pneumophila 14 1 383 P103
DIAGNOSIS OF UROGENITAL INFECTIONS (PCR)
Chlamydia trachomatis 44 4 346 P000
Mycoplasma hominis 46 4 544 P005
Mycoplasma genitalium 44 4 346 P006
Ureaplasma species 26 2 568 P015
Neisseria gonorrhoeae 44 4 346 P020
Gardnerella vaginalis 46 4 544 P025
DIAGNOSIS OF PROTOZOA INFECTIONS (PCR)
Trichomonas vaginalis 44 4 346 P010
Toxoplasma gondii 29 2 865 P012
DIAGNOSIS OF FUNGAL INFECTIONS (PCR)
Candida albicans (PCR) 47 4 643 P037
DIAGNOSIS OF HEPATITIS (PCR)
Hepatitis B quant. (HBV-DNA) 70 6 914 P040
Hepatitis B qualitive (HBV-DNA) 44 4 346 P045
Hepatitis C quant. (HCV-RNA) 337 33 288 P050
Hepatitis C qualitive (HCV-RNA) 51 5 038 P055
HCV-RNA (genotype determination) 62 6 124 P060
Hepatite G qual. (HGV-RNA) 53 5 235 P061
Hepatite D qual. (HDV-RNA) 53 5 235 P062
Hepatitis A Virus RNA (HAV-RNA) 53 5 235 P008
Genotype of hepatitis B 47 4 643 P063
Hepatitis C Virus RNA (ultrasensitive method) 99 9 779 P101
RNA/DNA of HIV type 1, ultrasensitive test (qualitative research) 299 29 535 P056
Definition of HIV RNA (type 1) (quantitative) 138 13 631 P132
GENETIC ANALYSIS
Cytogenetic study of the bone marrow (standard) 248 24 497 G117
SNP identification in human IL28B gene 79 7 803 G122
Hereditary Neuropathy with Liability to Pressure Palsy. Copy number variation PMP22 gene 365 36 054 G135
CYP2D6 analysis polymorphisms 186 18 373 G137
Determination of hereditary nonpolyposis colon cancer (Lynch syndrome) 572 56 501 G138
BRCA1 и BRCA2 polymorphism 298 29 436 G156
Sequence SCN1 A (Dravet syndrome) 1 096 108 260 G159
Fragile X mental retardation syndrome (methylation) 241 23 805 G160
Locus analysis of microdeletions AZF Y-chromosome (1person) 180 17 780 G163
Paternity test 638 63 020 G165
Non Invasive Fetal Rhesus factor Determination 250 24 694 G167
PGD of monogenic diseases (QF-PCR) (confirmed diagnosis and genotype) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) 1 208 119 323 G191
PGD of monogenic diseases (QF-PCR) (confirmed diagnosis genotype not known) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) договорная G192
Calreticulin (CALR) 266 26 275 G197
Genetic predisposition to breast cancer and ovarian cancer 197 19 459 G216
Genetic predisposition to breast cancer in long-term hormonal contraception 372 36 745 G218
Stomach cancer 721 71 219 G232
Pancreas cancer 462 45 635 G233
Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (shorten) 328 32 399 G235
Long QT syndrome 154 15 212 G256
Lactose intolerance 90 8 890 G264
Gilbert's syndrome - a confirmatory test 66 6 519 G265
Psoriasis 110 10 866 G268
Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form 570 56 303 G313
Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form and on paper 741 73 194 G314
Full sequencing of exome 1 587 156 760 G315
Panel "Diseases of conjunctive tissue" 1 052 103 914 G316
Panel "Patrimony of cardiopathy" 1 052 103 914 G317
Arrhythmogenic dysplasia/cardiomyopathy of the right stomach: search for mutations in the gene SCN5A 1 070 105 692 G318
Syndrome of lengthened interval QT (Sequencing of genes KCNQ 1, KCNE 1,KCNQ 2, KCNH2, KCNJ2, SCN5A, SCN4B, CAV3) extended, 8 of genes 997 98 481 G320
Velocardiofacial syndrome: searching for deletions in region 22q11 296 29 238 G324
PGD: QF-PCR assay of monogenic family disease, 1 embryo 252 24 892 G328
Molecular karyotyping abortion material OPTIMA 517 51 068 G376
PGS 24 chromosomes by a method of NGS (for patients with normal blood karyotype) 690 68 157 G379
PGD for structural chromosome rearrangements NGS (for patients with balanced chromosomal rearrang.) 654 64 601 G380
The allocation and storage of DNA 37 3 655 G388
Panel "Disorders of hemostasis" 30 tokens 332 32 794 G389
Cytogenetics: FISH (fluorescent crossbreeding in situ) (for one token) 292 28 843 G394
Cytogenetics: FISH (fluorescent crossbreeding in situ) with whole chromosome breakdown, 1 chromosome 292 28 843 G395
Cytogenetics: MDS FISH (fluorescent crossbreeding in situ) panel with (6 probes) 487 48 105 G396
Cytogenetics: FISH (fluorescent crossbreeding in situ) panel of MDS according to IPSS (9 probes) 708 69 935 G397
Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in AML (9 probes) 708 69 935 G398
Cytogenetics: FISH (fluorescent crossbreeding in situ) panel when ALL the (7 probes) 554 54 723 G399
Cytogenetics: FISH (fluorescent crossbreeding in situ) panel with multiple myeloma (10 probes) 730 72 108 G400
Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in CLL (8 probes) 620 61 242 G401
Cytogenetics: FISH (fluorescent crossbreeding in situ) panel (hypereosinophilic syndrome, chronic eosinophilic leukemia, chronic myeloproliferative neoplasms) 2 probes 443 43 758 G402
The study of the intestinal microbiota by the method of NGS sequencing of specific 16s RNA 329 32 498 G425
FISH-diagnostics (X and Y chromosomes) 296 29 238 G531
CHROMOSOMAL ANALYSIS
Karyotype (cytogenetic analysis) 253 24 991 G050
TISSUE TYPING
HLA TYPING B27 281 27 757 G020
MICROBIOLOGY
Bacteriology & Antibiogram 107 10 569 M000
Bacterioscopic stained smear 41 4 050 M003
Microbiological study of discharge from the urethra to urealyticum ureaplasma, mycoplasma of hominis, with resistogramm 62 6 124 M005
Determination of microbiocenosis by chromatography-mass spectrometry (MSMM) 185 18 274 M006
Bacterioscopic examination of a stained smear (without morphology) during blood culture 32 3 161 M007
Mycology & Fungigram 114 11 261 M010
Disbacteriosis 142 14 026 M100
Corynebacterium diphtheriae (BL) 39 3 852 M130
Enteropathogenic bacteria (BD) 44 4 346 M135
Staphylococcus aureus 69 6 816 M170
Yersinia enterocolitica (stool culture) 69 6 816 M350
Listeria (with resistance) 51 5 038 M560
The detection Candida anti-mannan antibodies in serum Platelia, Candida Ab Plus 87 8 594 M237
Determination of fungi metabolites (determination of Candida mannan antigen in blood serum, Platelia Candida Ag) 87 8 594 M238
Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (nose, pharynx, sinuses) 32 3 161 M239
Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (nose, pharynx, sinuses) 31 3 062 M240
Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (tela, stab sequestrate) 32 3 161 M241
Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (tela, stab sequestrate) 31 3 062 M242
Inoculation of N. meningitidis with the definition of sensitivity to antibiotics 26 2 568 M243
Microbiological examination of smears from the mucous membrane of the throat and nose for pertussis pathogens 34 3 358 M399
MICOLOGY
Microbiology of lavage fluid, nasopharyngeal swabs, wash water sinuses, ear discharge by fungi (microscopy and culture, 1 localization) 200 19 756 M160
Mycology of hair by dermatophytes (Dermatophyton) microscopy and culture 133 13 137 M055
Microbiology of blood by fungi (double reseeding) 174 17 187 M151
Micology Aspergillus spp. of sputum (microscopy and culture) 101 9 977 M090
Micology Cryptococcus neoformans of sputum (microscopy and culture) 174 17 187 M095
Mycology of sputum by fungi, microscopy and culture 101 9 977 M156
Microbiology of sputum by anaerobic and facultative anaerobic microbes (actinomycetes) 174 17 187 M175
Mycology Aspergillus spp. of nasopharyngeal swabs (culture) 146 14 422 M080
Microbiology of abscess by anaerobic and facultative anaerobic microbes (actinomycetes) 160 15 804 M171
Aspergillus niger. of ear discharge (micology), Aspergillus spp. culture and filamentous fungi 101 9 977 M131
Mycology of conjunctiva discharge by fungi (culture) 133 13 137 M136
Bacteriology of traumatic discharge by anaerobic and facultative anaerobic microbes (actinomycetes) 160 15 804 M165
Mycology of skin and nail samples by dermatophytes (Dermatophyton) culture, 1 localization 89 8 791 M060
Mycology Cryptococcus neoformans of cerebrospinal fluid (microscopy and culture) 101 9 977 M116
Metabolite of fungi (Cryptococcus antigen in "Cryptococcus", BIO-RAD, mannan) 120 11 853 M195
Metabolite of fungi (Aspergillus antigen in Aspergillus EIA, BIO-RAD, galactomannan) 153 15 113 M235
Aspergillus spp. Antibodies (Aspergillus fumigatus Igg) 107 10 569 M236
COMPLEX LABORATORY TESTS
Cardiorisk 584 57 686 K001
Lipidic screening 281 27 757 K002
Liver Function 160 15 804 K003
TORCH 504 49 784 K004
Thyroid gland 319 31 510 K005
Anemia 292 28 843 K006
Biochemical screening 247 24 398 K008
Complex "Chemotherapy. Biochemical screening" №1 120 11 853 K010.1
Complex "Chemotherapy. Biochemical screening" №2 118 11 656 K010.2
Fibro Test/ Acti Test 398 39 313 K011
FibroMax Test 533 52 648 K012
LifeSpan Lab Pre-Check Male 292 28 843 K013
LifeSpan Lab Pre-Check Female 292 28 843 K014
NASH - FibroTest 129 12 742 K015
Express Health Certificate at home 278 27 460 CVD21
Express Health Certificate at home 253 24 991 CVD21.1
Anti- COVID-19, IgM/IgG + Vaccination against Influenza (Ultrix Quadri) 210 20 743 CVD22
Anti- COVID-19, IgM/IgG + Vaccination against Influenza (Ultrix Quadri) at home 84 8 297 CVD22.1
Anti- COVID-19, IgM/IgG + Vaccination against Influenza (Ultrix Quadri) for children 304 30 028 CVD23
PREDILECTION OF BREAST / OVARY CANCER > QUALITY EXPRESSION OF CHYMERA ONCOGENES BY RT-PCR
BCR-ABL p210 t(9;22) 101 9 977 G052
BCR-ABL p190 t(9;22) 101 9 977 G053
BCR-ABL p230 t(9;22) 101 9 977 G054
MUTATIONS, CHIMERISM
Mutation in D816V gene c-KIT, typical of mastocytosis 73 7 211 G097
Mutation profile: V617F Jak-2, delection 12 exon Jak-2, Mpl-1 W515L/K. С 196 19 360 G098
Mutation V617F in 14 exon gene Jak-2 kinase – quantity 118 11 656 G099
Hemochromatosis, mutation in a gene HFE-C282Y and H63D (PCR- detection) 91 8 989 G104
Mutation V617F in 14exon gene Jak-2 kinase -quality 69 6 816 G106
Deletion in 12 exon gene Jak-2 kinase 63 6 223 G107
Determination of thrombophilia markers (FII, FV, MTHFR) 173 17 089 G114
Search for mutations in the ATL1 gene in Strumpel's spastic paraplegia 1 033 102 037 G298
Search 12 the most frequent mutations in the gene ATP7B (Wilson Disease-Konovalova) 219 21 632 G371
Search of mutations in the gene ATP7B (Wilson Disease-Konovalova) 993 98 086 G372
Search identified in this family of mutations have a relative (Wilson Disease-Konovalova) 207 20 447 G373
PDGFRα, FIP1L1 - markers of eosinophilia 163 16 101 G386
Genotyping on the RH factor, including heterozygous carrier 200 19 756 G387
Panel "Phacomatosis and hereditary cancer" 858 84 751 G390
Screening for hereditary diseases (2500 genes) 1 052 103 914 G409
Screening for hereditary diseases (5 diseases, 15 mutations) 145 14 323 G410
Search for frequent mutations in genes CFTR, PAH, SMN1, GJB2 422 41 684 G411
Search 9 most frequent mutations in the CYP210HB gene 282 27 855 G412
Analysis of spinal amyotrophy carrier for married couple (2 pers.) 317 31 312 G413
Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with the report in the electronic form 1 231 121 595 G415
Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with report in electronic form and on paper 1 661 164 070 G416
Solo Risk:hereditary mutations associated with the risk of hereditary oncol dis. in an electr. form 1 624 160 415 G417
Solo Risk:hereditary mut assoc with the risk of hereditary oncol dis in an electr form,a paper car 1 808 178 590 G418
The blood test for the syndrome Gerstmann-Straussler-Sheinker: search for mutations in the gene PRNP 396 39 116 G442
Complex genetic research: hereditary diseases of the gastrointestinal tract 855 84 455 G443
Full genome sequencing GenomeUNI 2 418 238 844 G445
Research on the genome FERTY 1 965 194 098 G446
Search for mutations in the FKTN gene (Muscular dystrophy of the Fukuyama type) 788 77 837 G447
Finding a relative’s identified mutations in this family (Muscular dystrophy of the Fukuyama type) 207 20 447 G448
Search for frequent mutations in CAPN3, FKRP, ANO5, SGCA genes (muscular dystrophy of the lumbar) 219 21 632 G449
Finding mutations in the LMNA (Emery-Dreyfus muscular dystrophy) 554 54 723 G457
Finding mutations in the FHL1 gene (Emery-Dreyfus muscular dystrophy) 443 43 758 G458
Search for deletions and duplications in the DMD gene in boys (Duchenne/Becker muscular dystrophy) 397 39 215 G461
Search deletions and duplications in the patient's relatives in the female line (Duchenne/Becker muscular dystrophy) 431 42 573 G462
Search for a point mutation identified in this family from a relative (Duchenne/Becker muscular dystrophy) 151 14 915 G464
Prenatal DNA diagnosis (Duchenne/Becker muscular dystrophy) 448 44 252 G465
Chromosomal micromatrix analysis of the exon level 1 108 109 446 G468
Gene analysis in primary immunodeficiency and hereditary anemias 839 82 874 G520
Analysis of the number of CAG repeats in the androgen receptor (AR) gene 111 10 964 G521
Chromosomal micromatrix analysis "Standard" 554 54 723 G523
Chromosomal microarray analysis prenatal targeted 406 40 104 G524
Microarray assay from tissue blocks 1 439 142 141 G525
Extra charge for urgency (with a minimum of 50) увел. тарифа на 50%/ extra charge 50% URG
EXPRESS DIAGNOSTICS > HISTOLOGICAL LABORATORY > SURGICAL SAMPLES
Histology of surgical samples, 1 sample 284 28 053 M200
Histological examination of the placenta 380 37 535 M206
Histology of tumor surgical samples 516 50 969 H250
Intraoperative (urgent) histology and cytology 266 26 275 H299
Histology of breast wide local excision (lumpectomy) specimen 516 50 969 H270
Histology of mastectomy speciment 487 48 105 H271
Histology of sentinel lymph node with IHC if necessary 354 34 967 H272
Histology of lymph node dissection speciment 284 28 053 H273
Intraoperative control of resection margins by Mohs micrographic surgery 317 31 312 H277
DIAGNOSTIC (BIOPSY) MATERIAL
Histology simple 1-2 samples 168 16 595 M201
Hystology with supplementary staining for helicobacter pylori 301 29 732 M202
Multiple histology 3 samples and more 457 45 141 M203
Histology of scrapings of the uterus 284 28 053 H205
Histology of the mammary gland punctates 284 28 053 H206
Histology of liver bioptates 284 28 053 H207
Histology of CT-guideline needle biopsy 528 52 155 H208
Histology of skin (PUNCH-biopsy) 284 28 053 H209
Histology of skin tumors 263 25 979 H210
Histology of bone marrow patho bioptate 354 34 967 H211
CONSULTATIONS OF SPECIMENS
Consultation of histology and cytology slides 208 20 546 H230
Consultation with the making of histology specimens with paraffin blocks 297 29 337 H231
Consultation with the making of specimens and immunohistochemistry 475 46 919 H232
Consultation of histology specimens of doctor specialist - pathologist from USA (telepathology) 985 97 296 H233
Scanning histological (cytology) specimens to make digital copies (1slide) 123 12 150 H240
CYTOLOGY
Citology / 1 lame 100 9 878 M300
Cytologic cervical smear (Pap Smear) 125 12 347 M301
Complex immunocytochemical study of thyroid neoplasms 570 56 303 M303
Complex cytological and immunocytochemical examination of pleural fluid 140 13 829 M304
Cytology of aspirates from the uterus, the prints with an intrauterine device 103 10 174 Z302
Cytology of the mammary gland 100 9 878 Z303
Cytology of the thyroid gland punctate 155 15 311 Z304
Cytology of liquid 103 10 174 Z305
Cytology of endoscopic material 75 7 408 Z306
Cytology of scrapings from the surface of the skin and mucous 103 10 174 Z307
Cytology of surgical samples 103 10 174 Z308
Cytology of the lymph nodes punctate 125 12 347 Z309
Urine cytology for diagnosis cancer of the urinary tract 103 10 174 Z311
Urgent cytology performed during endoscopic procedures (preparation and evaluation of cytologic drug clinical laboratory diagnostic by cytologist) 190 18 768 Z315
IMMUNOHISTOCHEMISTRY
Immunohistochemistry of breast cancer (receptors PR, ER and Her2/neu + Ki-67) 370 36 548 I001
Immunohistochemical differential diagnosis of tumors 516 50 969 I002
Immunohistochemistry of one marker panel differential diagnosis 270 26 670 I003
Immunohistochemical diagnosis of lymphoproliferative disease (lymphoma) 607 59 958 I004
Immunohistochemical (IHC) testing for Mismatch Repair Proteins in carcinomas to exclude Lynch syndrome 323 31 905 I005
Immunocytochemistry 323 31 905 I006
Immunohistochemistry with assessment of the mutational status of the ALK gene 278 27 460 I007
Complex histological and immunohistochemical analysis of biopsies of the bladder 323 31 905 I008
Immunohistochemical study of PDL-1 gene expression 348 34 375 I009
Immunohistochemical study of up to 5 antibodies 289 28 547 I010
Immunohistochemical study from 5 to 10 antibodies 457 45 141 I011
Immunohistochemical study from 10 to 20 antibodies 684 67 564 I012
Complex histological and immunohistochemical study of biopsies of the prostate 570 56 303 I013
Comprehensive histological and immunohistochemical examination of surgical tissue sample 696 68 749 I014
GENETIC ANALYSIS
Identification of the codeletion 1p/19q by in situ-hybridization in a sample of tumor tissue 598 59 069 I506
Determination of the mutational status of the ROS1 gene by in situ hybridization in a tumor tissue sample 598 59 069 I507
Determination of the mutational status of the MET gene by in situ hybridization in a tumor tissue sample 598 59 069 I509
Biochemical screening of the first trimester of pregnancy for the ASTRAIA program (without calculating the risks of fetal pathology) (8-14 weeks) Pregnancy-associated protein A (PAPP-A), beta-hCG Free subunit 100 9 878 G532
Preimplantation genetic testing of monogenic diseases. PGT-M of monogenic familial disease, 1 embryo (additional study on anueploidy by NGS method) 475 46 919 G533
Comparison of data. Panel: "Pharmacogenetics: Cytochrome CYP2C9" 56 5 532 G534
Data analysis during genome-wide DNA amplification of a biological material sample 443 43 758 G535
Determination of translocations of genes NTRK1, NTRK2, NTRK3 1 793 177 108 G536
Preimplantation genetic testing "PGT-SNP" 307 30 325 G567
Noninvasive preimplantation genetic testing "niPGT" 492 48 599 G568
Identification of activating mutations that determine sensitivity to targeted therapy
KRAS mutation exon 2 (codon12 13) (sensitivity to cetuximab) 381 37 634 G200
EGFR mutation exons 18,19,21 (sensitivity to gefitinib/erlotinib) 484 47 808 G201
BRAF mutation exon 15 (V600E) (sensitivity to vemurafenib for melanoma and sensitivity to cetuximab for colorectal cancer 321 31 708 G203
ALK gene displacement (sensitivity to crizotinib and pemetrexed) 598 59 069 G206
Determination of the methylation status of the promoter body and MGMT gene 321 31 708 G207
Study of genes mutations of BRCA1/BRCA2, CHEK2, ATM in tumor tissue by PCR method 1 506 148 759 G419
Molecular genetic testing of mutations in IDH2 gene in a sample of tumor tissue 348 34 375 G427
Molecular genetic study of mutations in the PIK3CA gene in a tumor tissue sample 381 37 634 G436
Molecular genetic research in the NRAS gene in biopsy/surgical tissue sample 321 31 708 G437
Solo Genetics Advanced: tumour tissue analysis (50 biomarkers) by NGS method 1 918 189 455 G440
Endometrial receptivity assessment (ERA test) 2 010 198 543 G499